This inflammatory environment promotes insulin resistance by activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and c-Jun N-terminal kinase (JNK) pathways that, in turn, lead to the decline of insulin secretion by pancreatic b-cells [14,15]. The gene discussed is INS; the disease is Insulin resistance.